672 related articles for article (PubMed ID: 24486372)
21. Third-generation flavivirus vaccines based on single-cycle, encapsidation-defective viruses.
Widman DG; Frolov I; Mason PW
Adv Virus Res; 2008; 72():77-126. PubMed ID: 19081489
[TBL] [Abstract][Full Text] [Related]
22. Formalin-inactivated whole virus and recombinant subunit flavivirus vaccines.
Eckels KH; Putnak R
Adv Virus Res; 2003; 61():395-418. PubMed ID: 14714438
[TBL] [Abstract][Full Text] [Related]
23. Nucleic acid-based inhibition of flavivirus infections.
Stein DA; Shi PY
Front Biosci; 2008 Jan; 13():1385-95. PubMed ID: 17981637
[TBL] [Abstract][Full Text] [Related]
24. American Society of Tropical Medicine and Hygiene--55th Annual Meeting. Vaccine development against flaviviruses. 12-16 November 2006, Atlanta, GA, USA.
Klade C
IDrugs; 2007 Feb; 10(2):96-8. PubMed ID: 17285458
[No Abstract] [Full Text] [Related]
25. Membrane and envelope virus proteins co-expressed as lysosome associated membrane protein (LAMP) fused antigens: a potential tool to develop DNA vaccines against flaviviruses.
Dhalia R; Maciel M; Cruz FS; Viana IF; Palma ML; August T; Marques ET
An Acad Bras Cienc; 2009 Dec; 81(4):663-9. PubMed ID: 19893892
[TBL] [Abstract][Full Text] [Related]
26. Are we prepared for emerging flaviviruses in Europe? Challenges for vaccination.
Kaaijk P; Luytjes W
Hum Vaccin Immunother; 2018 Feb; 14(2):337-344. PubMed ID: 29053401
[TBL] [Abstract][Full Text] [Related]
27. Recent advances in flavivirus antiviral drug discovery and vaccine development.
Ray D; Shi PY
Recent Pat Antiinfect Drug Discov; 2006 Jan; 1(1):45-55. PubMed ID: 18221133
[TBL] [Abstract][Full Text] [Related]
28. Lipids and flaviviruses, present and future perspectives for the control of dengue, Zika, and West Nile viruses.
Martín-Acebes MA; Vázquez-Calvo Á; Saiz JC
Prog Lipid Res; 2016 Oct; 64():123-137. PubMed ID: 27702593
[TBL] [Abstract][Full Text] [Related]
29. Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses.
Mackenzie JS; Gubler DJ; Petersen LR
Nat Med; 2004 Dec; 10(12 Suppl):S98-109. PubMed ID: 15577938
[TBL] [Abstract][Full Text] [Related]
30. [Flavivirus encephalitis: focus on West Nile encephalitis].
Lim CK; Takasaki T
Rinsho Byori; 2005 Aug; 53(8):721-7. PubMed ID: 16190358
[TBL] [Abstract][Full Text] [Related]
31. [Prospects for treating mosquito-borne flavivirus encephalitides].
Platonov AE; Karan' LS; Vengerov IuIa; Galimzianov KhM
Ter Arkh; 2009; 81(11):68-73. PubMed ID: 20141019
[TBL] [Abstract][Full Text] [Related]
32. Domain III peptides from flavivirus envelope protein are useful antigens for serologic diagnosis and targets for immunization.
Chávez JH; Silva JR; Amarilla AA; Moraes Figueiredo LT
Biologicals; 2010 Nov; 38(6):613-8. PubMed ID: 20817489
[TBL] [Abstract][Full Text] [Related]
33. Prospects for development of a vaccine against the West Nile virus.
Monath TP
Ann N Y Acad Sci; 2001 Dec; 951():1-12. PubMed ID: 11797767
[TBL] [Abstract][Full Text] [Related]
34. Recent Advancements in Mosquito-Borne Flavivirus Vaccine Development.
Wu B; Qi Z; Qian X
Viruses; 2023 Mar; 15(4):. PubMed ID: 37112794
[TBL] [Abstract][Full Text] [Related]
35. DNA vaccines for flaviviruses.
Putnak R; Porter K; Schmaljohn C
Adv Virus Res; 2003; 61():445-68. PubMed ID: 14714440
[No Abstract] [Full Text] [Related]
36. Safety testing for neurovirulence of novel live, attenuated flavivirus vaccines: infant mice provide an accurate surrogate for the test in monkeys.
Monath TP; Myers GA; Beck RA; Knauber M; Scappaticci K; Pullano T; Archambault WT; Catalan J; Miller C; Zhang ZX; Shin S; Pugachev K; Draper K; Levenbook IS; Guirakhoo F
Biologicals; 2005 Sep; 33(3):131-44. PubMed ID: 15975826
[TBL] [Abstract][Full Text] [Related]
37. Flaviviruses and Kidney Diseases.
Burdmann EA
Adv Chronic Kidney Dis; 2019 May; 26(3):198-206. PubMed ID: 31202392
[TBL] [Abstract][Full Text] [Related]
38. Yellow fever and Japanese encephalitis vaccines: indications and complications.
Marfin AA; Eidex RS; Kozarsky PE; Cetron MS
Infect Dis Clin North Am; 2005 Mar; 19(1):151-68, ix. PubMed ID: 15701552
[TBL] [Abstract][Full Text] [Related]
39. Historical Perspectives on Flavivirus Research.
Holbrook MR
Viruses; 2017 Apr; 9(5):. PubMed ID: 28468299
[TBL] [Abstract][Full Text] [Related]
40. Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen.
Monath TP; Guirakhoo F; Nichols R; Yoksan S; Schrader R; Murphy C; Blum P; Woodward S; McCarthy K; Mathis D; Johnson C; Bedford P
J Infect Dis; 2003 Oct; 188(8):1213-30. PubMed ID: 14551893
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
